Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

Clinical Development

FDA Commits to Increasing Diversity in Clinical Trials

The move follows steps announced by the EMA and the MHRA to ensure clinical trials are more reflective of patient populations.
Clinical Development

Predicting Parkinson’s Disease with Machine Learning

Understanding machine learning’s role in providing a biomarker for the neurological condition.
Diagnostic Development

Study Reveals Altered Spontaneous Brain Activity in People with Down Syndrome

A new study has revealed that using functional magnetic resonance techniques shows the differences in the spontaneous activity of the brain in people with Down syndrome compared to the general population.
Diagnostic Development

The Ethical Issues of Pre-Emptive Dementia Diagnosis

If you were at risk of developing Alzheimer’s disease, would you want to know?
Diagnostic Development

Low-Cost Method for Cancer Testing

The Heatrich-BS assay is a novel low-cost sequencing method for low-cost cancer testing.
Genome Editing

Novel Genome Editing Techniques: What Will Come Next after CRISPR-Cas9?

The gene editing field has exploded in the last ten years, with methods such as CRISPR-Cas9 becoming well-established in the pre-clinical sphere. However, complications in clinical applications have led some researchers to explore alternatives.
Diagnostic Development

Functional Cure Biomarker for Hepatitis B Virus

Study suggests the haplotype number for hepatitis B virus could act as a predictive biomarker for functional cure during antiviral therapies.
Diagnostic Development

Can Protein Shapes Indicate Parkinson's Disease?

The first ever potential biomarker for Parkinson’s disease has been discovered.
Diagnostic Development

Urinary Biomarker Detects Early Onset of Alzheimer’s Disease

Discovery of a new sensitive urinary biomarker could pave the way for cost-effective and large-scale screening of neurodegenerative disease.
Diagnostic Development

Diagnostic Biomarkers Discovered for Lyme Disease

New hope raised for the early detection and treatment of the tick-borne illness.
Diagnostic Development

Predicting Heart Disease Risk with ‘Good’ Cholesterol: Is it Still Viable?

A new study analysing the cholesterol levels of black adults challenges traditional perceptions of its role in predicting heart disease risk.
Spatial Analysis

Rapid Development of Spatial Signatures as Predictive Biomarkers for Immunotherapy Response

On-Demand Webinar featuring Dr Alessio Colombo, Application Scientist at Akoya

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery